Biotest AG — Earnings Release 2004

Nov 22, 2004

News Details

Corporate | 22 November 2004 13:00

Biotest increases operating result by 70%

Corporate-news announcement sent by DGAP. The sender is solely responsible for the contents of this announcement. ——————————————————————————– Biotest increases operating result by 70% Dreieich, November 22, 2004. Biotest AG has increased its year-to-date operating result in Q3 by 70% compared to the same period of the previous year – from EUR 7.6 million to EUR 12.9 million. Sales in the two divisions – Pharmaceutical and Diagnostic – were up 2.2% in Q3 on the previous year, totaling EUR 163.1 million after the first nine months, at almost the same level as in 2003 (EUR 164.3 million). The German and European markets enjoyed positive growth in the group, whereas sales activities in low-margin regions such as Asia and South America were consciously restricted. Total assets decreased from EUR 350 million at the end of 2003 to a current total of EUR 337 million. Financial debt also decreased by around EUR 12 million. Liabilities were reduced by a total of approx. EUR 15 million compared to the end of the year. Biotest is forecasting a significantly improved operating result and positive earnings before taxes (EBT) for 2004 as a whole, despite sales being down slightly on the previous year. Biotest AG The Managing Board end of message, (c)DGAP 22.11.2004 ——————————————————————————– WKN: 522720; ISIN: DE0005227201; Index: Listed: Amtlicher Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin- Bremen, Düsseldorf, Hamburg und Stuttgart 221300 Nov 04